Ekkehard Grünig

27.2k total citations · 7 hit papers
253 papers, 11.5k citations indexed

About

Ekkehard Grünig is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, Ekkehard Grünig has authored 253 papers receiving a total of 11.5k indexed citations (citations by other indexed papers that have themselves been cited), including 235 papers in Pulmonary and Respiratory Medicine, 131 papers in Cardiology and Cardiovascular Medicine and 33 papers in Genetics. Recurrent topics in Ekkehard Grünig's work include Pulmonary Hypertension Research and Treatments (225 papers), Cardiovascular Function and Risk Factors (64 papers) and Heart Failure Treatment and Management (38 papers). Ekkehard Grünig is often cited by papers focused on Pulmonary Hypertension Research and Treatments (225 papers), Cardiovascular Function and Risk Factors (64 papers) and Heart Failure Treatment and Management (38 papers). Ekkehard Grünig collaborates with scholars based in Germany, United States and Italy. Ekkehard Grünig's co-authors include Hossein Ardeschir Ghofrani, Nazzareno Galiè, Marius M. Hoeper, Nicola Ehlken, Zhi‐Cheng Jing, Vallerie V. McLaughlin, Marc Humbert, Friedrich Grimminger, Lewis J. Rubin and Stephan Rosenkranz and has published in prestigious journals such as New England Journal of Medicine, Circulation and Nature Communications.

In The Last Decade

Ekkehard Grünig

232 papers receiving 11.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Riociguat for the Treatment of Pulmonary Arterial Hypertension

2013 944 citations Hossein Ardeschir Ghofrani, Nazzareno Galiè et al. profile →
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension

2015 750 citations Nazzareno Galiè, Joan Albert Barberà et al. profile →
Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study

2013 541 citations Christopher P. Denton, Ekkehard Grünig et al. Annals of the Rheumatic Diseases profile →
Risk stratification and medical therapy of pulmonary arterial hypertension

2018 521 citations Nazzareno Galiè, Ekkehard Grünig et al. European Respiratory Journal profile →
Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model

2017 438 citations Marius M. Hoeper, Christina A. Eichstaedt et al. European Respiratory Journal profile →
Imatinib Mesylate as Add-on Therapy for Pulmonary Arterial Hypertension

2013 411 citations Marius M. Hoeper, Robyn J. Barst et al. Circulation profile →
Genetics and Genomics of Pulmonary Arterial Hypertension

2013 359 citations Florent Soubrier, Wendy K. Chung et al. profile →

Peers

Countries citing papers authored by Ekkehard Grünig

Since Specialization

Citations

This map shows the geographic impact of Ekkehard Grünig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ekkehard Grünig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ekkehard Grünig more than expected).

Fields of papers citing papers by Ekkehard Grünig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ekkehard Grünig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ekkehard Grünig. The network helps show where Ekkehard Grünig may publish in the future.

Co-authorship network of co-authors of Ekkehard Grünig

This figure shows the co-authorship network connecting the top 25 collaborators of Ekkehard Grünig. A scholar is included among the top collaborators of Ekkehard Grünig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ekkehard Grünig. Ekkehard Grünig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Predicting Response to Switching From Phosphodiesterase Type 5 Inhibitor to Riociguat in Patients With Pulmonary Arterial Hypertension: Biomarker and Responder Analysis of the RESPITE and REPLACE Studies 2025 ·Pulmonary Circulation ·James R. Klinger, Hikmet Al‐Hiti, Sung‐A Chang, Hyuk‐Jae Chang, Hossein Ardeschir Ghofrani, Ekkehard Grünig, Marius M. Hoeper, Pavel Jansa, Jaquelina Sonoe Ota Arakaki, Tomás Pulido, Gérald Simonneau, Carmine Dario Vizza, (unknown), Christian Meier, G. Meyer	0
2	Single-Tablet Combination Therapy of Macitentan/Tadalafil for Patients with Pulmonary Arterial Hypertension: Qualitative Interview Study of the A DUE Phase 3 Trial 2025 ·Advances in Therapy ·Fenling Fan, Stacy N. Davis, (unknown), Kelly Chin, (unknown), Ekkehard Grünig, (unknown), Pavel Jansa, (unknown), (unknown), Armando A. Rodriguez, Jason A. Randall	1
3	The nitric oxide–soluble guanylate cyclase–cGMP pathway in pulmonary hypertension: from PDE5 to soluble guanylate cyclase 2024 ·European Respiratory Review ·Raymond L. Benza, Ekkehard Grünig, Peter Sandner, Johannes‐Peter Stasch, Gérald Simonneau	18
4	Effect of Eccentric Cycling on Oxygen Uptake and Hemodynamics in Patients With Pulmonary Vascular Disease 2024 ·Julian Müller, Simon Schneider, (unknown), (unknown), Esther I. Schwarz, Christoph Bauer, Ekkehard Grünig, Malcolm Kohler, Mona Lichtblau, Silvia Ulrich	0
5	Effect on Exercise Capacity and Long-Term Safety and Tolerability of Macitentan and Tadalafil as a Single-tablet Combination in Patients With Pulmonary Arterial Hypertension From the A DUE Open-label Interim Analysis 2024 ·Kelly Chin, Pavel Jansa, Ekkehard Grünig, J. Hauser, (unknown), (unknown), Hany Rofael, (unknown)	1
6	Effect of ambrisentan in patients with systemic sclerosis and mild pulmonary arterial hypertension: long-term follow-up data from EDITA study 2024 ·Arthritis Research & Therapy ·Panagiota Xanthouli, (unknown), Hanns-Martin Lorenz, Norbert Blank, Christina A. Eichstaedt, Satenik Harutyunova, Benjamin Egenlauf, (unknown), Christopher P. Denton, Ekkehard Grünig, Nicola Benjamin	2
7	Conseil génétique et dépistage de l’hypertension artérielle pulmonaire – consensus du Consortium international pour les études génétiques dans l’HTAP – version française 2023 ·Revue des Maladies Respiratoires ·David Montani, Christina A. Eichstaedt, Catharina Belge, Wendy K. Chung, Stefan Gräf, Ekkehard Grünig, Marc Humbert, Rozenn Quarck, Jair Tenorio, Florent Soubrier, Richard C. Trembath, Nicholas W. Morrell	1
8	Safety and effectiveness of standardized exercise training in patients with pulmonary hypertension associated with heart failure with preserved ejection fraction (TRAIN-HFpEF-PH): study protocol for a randomized controlled multicenter trial 2023 ·Trials ·Eglė Palevičiūtė, Jelena Čelutkienė, (unknown), Lina Gumbienė, Elena Jurevičienė, Diana Zakarkaitė, (unknown), Christina A. Eichstaedt, Nicola Benjamin, Ekkehard Grünig	1
9	Riociguat and the right ventricle in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension 2022 ·European Respiratory Review ·Raymond L. Benza, David Langleben, Anna R. Hemnes, Anton Vonk Noordegraaf, Stephan Rosenkranz, Thenappan Thenappan, Paul M. Hassoun, Ioana R. Preston, Stefano Ghio, Roberto Badagliacca, Carmine Dario Vizza, Iréne Lang, Christian Meier, Ekkehard Grünig	10
10	The effect of exercise training and physiotherapy on left and right heart function in heart failure with preserved ejection fraction: a systematic literature review 2022 ·Heart Failure Reviews ·Eglė Palevičiūtė, (unknown), Christina A. Eichstaedt, Nicola Benjamin, Benjamin Egenlauf, Ekkehard Grünig, Jelena Čelutkienė	5
11	Clinical outcomes stratified by baseline functional class after initial combination therapy for pulmonary arterial hypertension 2019 ·Respiratory Research ·R. James White, Anton Vonk Noordegraaf, Stephan Rosenkranz, Ronald J. Oudiz, Vallerie V. McLaughlin, Marius M. Hoeper, Ekkehard Grünig, Hossein Ardeschir Ghofrani, Murali M. Chakinala, Joan Albert Barberà, Christiana Blair, Jonathan Langley, Adaani Frost	17
12	Haemodynamic phenotypes and survival in patients with systemic sclerosis: the impact of the new definition of pulmonary arterial hypertension 2019 ·Annals of the Rheumatic Diseases ·Panagiota Xanthouli, Suzana Jordan, (unknown), Alberto M. Marra, Norbert Blank, Benjamin Egenlauf, Matthias Gorenflo, Satenik Harutyunova, Hanns-Martin Lorenz, Christian Nagel, (unknown), Mona Lichtblau, Charlotte Berlier, Silvia Ulrich, Ekkehard Grünig, Nicola Benjamin, Oliver Distler	62
13	Imatinib Mesylate as Add-on Therapy for Pulmonary Arterial Hypertension breakdown → 2013 ·Circulation ·Marius M. Hoeper, Robyn J. Barst, Robert C. Bourge, Jeremy Feldman, Adaani Frost, Nazzareno Galiè, Miguel Ángel Gómez‐Sánchez, Friedrich Grimminger, Ekkehard Grünig, Paul M. Hassoun, Nicholas W. Morrell, Andrew J. Peacock, Toru Satoh, Gérald Simonneau, Victor F. Tapson, Ferràn Torres, David Lawrence, Deborah A. Quinn, Hossein Ardeschir Ghofrani	411
14	Riociguat for the treatment of pulmonary arterial hypertension (PAH): A responder analysis from the phase III PATENT-1 study 2013 ·European Respiratory Journal ·Ekkehard Grünig, Nazzareno Galiè, Marc Humbert, Anne Keogh, David Langleben, Lewis J. Rubin, Rudolf Speich, Arno Fritsch, Neil Davie, Hossein Ardeschir Ghofrani	1
15	Correlation of improvements in hemodynamics and exercise capacity in patients with PAH: Results from the phase III PATENT-1 study 2013 ·European Respiratory Journal ·Nazzareno Galiè, Friedrich Grimminger, Ekkehard Grünig, Marc Humbert, Zhi‐Cheng Jing, Anne Keogh, David Langleben, Lewis J. Rubin, Michael Ochan Kilama, Arno Fritsch, Neil Davie, Hossein Ardeschir Ghofrani	5
16	Efficacy of riociguat in patients with inoperable CTEPH vs persistent/recurrent PH after pulmonary endarterectomy (PEA): Results from the phase III CHEST-1 study 2013 ·European Respiratory Journal ·Eckhard Mayer, Andrea Maria D’Armini, Hossein Ardeschir Ghofrani, Ekkehard Grünig, Pavel Jansa, Nick H. Kim, Gérald Simonneau, Adam Torbicki, Chen Wang, Martin R. Wilkins, Neil Davie, Arno Fritsch, Marius M. Hoeper	2
17	Safety and efficacy of exercise training in various forms of pulmonary hypertension 2012 ·European Respiratory Journal ·Ekkehard Grünig, Mona Lichtblau, Nicola Ehlken, Hossein Ardeschir Ghofrani, Frank Reichenberger, Gerd Staehler, Michael Halank, Christine Fischer, Hans‐Jürgen Seyfarth, Hans Klose, Andreas Meyer, Stephan Sorichter, Heinrike Wilkens, Stephan Rosenkranz, Christian Opitz, Hanno Leuchte, Gabriele Karger, Rudolf Speich, Christian Nagel	161
18	Exercise and Respiratory Training Improve Exercise Capacity and Quality of Life in Patients With Severe Chronic Pulmonary Hypertension 2006 ·Circulation ·Derliz Mereles, Nicola Ehlken, (unknown), Sedigheh Ghofrani, Marius M. Hoeper, Michael Halank, F. Joachim Meyer, Gabriele Karger, J. Buss, Jana Juenger, Nicole Holzapfel, Christian Opitz, Jörg Winkler, Felix Herth, Heinrike Wilkens, Hugo A. Katus, Horst Olschewski, Ekkehard Grünig	466
19	Hypoxia Decreases Exhaled Nitric Oxide in Mountaineers Susceptible to High-Altitude Pulmonary Edema 2001 ·American Journal of Respiratory and Critical Care Medicine ·Thilo Busch, Peter Bärtsch, D. Pappert, Ekkehard Grünig, Wulf Hildebrandt, (unknown), K. J. Falke, Erik R. Swenson	162
20	Dilated Cardiomyopathy and Sensorineural Hearing Loss 2000 ·Circulation ·Jost Schönberger, Hara Levy, Ekkehard Grünig, Somkiat Sangwatanaroj, Diane Fatkin, Calum A. MacRae, (unknown), Christopher F. Halpin, Roland D. Eavey, Edward F. Philbin, Hugo A. Katus, J G Seidman, Christine E. Seidman	64

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact